Home » Regions » Global News » Vince & Associates expands early phase gastrointestinal capabilities

Vince & Associates expands early phase gastrointestinal capabilities

Monday, August 26, 2013

Vince & Associates Clinical Research, a provider of early phase clinical research services to the global biopharmaceutical industry, has expanded its capabilities in the gastrointestinal (GI) therapeutic area with the addition of a dedicated endoscopy suite at its Clinical Pharmacology Unit.

“Vince & Associates Clinical Research has successfully conducted a number of studies evaluating potential therapies in patients with gastrointestinal disorders. To supplement ongoing research, VACR has established an endoscopy suite to offer on-site access to a wide range of endoscopic procedures,” said Dr. Brad Vince, chief executive officer and medical director.

The suite is equipped with advanced and minimally invasive video endoscopy technology from Olympus EndoTherapy. Procedures can be viewed remotely on a large screen and documented by video or still photography. The suite includes two sources of suction as well as resuscitation and medication stations to address patient safety and equipment is maintained at the purpose built disinfection station.

Vince & Associates has reached out to Summit Gastroenterology for its medical expertise to complement the new research capabilities. The board certified gastroenterologists have been asked to join the Vince & Associates’ clinical research team as investigators, bringing clinical experience as GI specialists.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!